According to Chembio Diagnostics's latest financial reports the company's current revenue (TTM) is $48.33 M. In 2021 the company made a revenue of $36.92 M an increase over the years 2020 revenue that were of $30.45 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $48.33 M | 30.91% |
2021 | $36.92 M | 21.26% |
2020 | $30.45 M | -11.64% |
2019 | $34.46 M | 3.16% |
2018 | $33.4 M | 39.12% |
2017 | $24.01 M | 34.4% |
2016 | $17.86 M | -26.33% |
2015 | $24.25 M | -12.26% |
2014 | $27.64 M | -6.44% |
2013 | $29.54 M | 15.38% |
2012 | $25.61 M | 32.09% |
2011 | $19.38 M | 16.06% |
2010 | $16.7 M | 20.75% |
2009 | $13.83 M | 25.2% |
2008 | $11.04 M | 19.7% |
2007 | $9.23 M | 41.96% |
2006 | $6.5 M | 65.01% |
2005 | $3.94 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Trinity Biotech
TRIB | $61.44 M | 27.10% | ๐ฎ๐ช Ireland |
QuidelOrtho QDEL | $2.99 B | 6,101.50% | ๐บ๐ธ USA |
OraSure Technologies OSUR | $0.40 B | 738.79% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | $2.67 B | 5,426.00% | ๐บ๐ธ USA |